Bilayer composition for the sustained release of acetaminophen and tramadol
View Patent ↗The invention relates to a bilayer composition for the delivery of acetaminophen and tramadol over at least a twelve hour period following initial administration. A single administration of the bilayer composition can provide analgesia starting in less than half an hour to about one hour after initial administration with a duration of at least twelve hours after initial administration.
1. A bilayer composition for the delivery of tramadol and acetaminophen, the bilayer composition comprising:
a. a first layer defining a rapid release portion of the composition and comprising a first amount of acetaminophen; and
b. a second layer defining a sustained release portion of the composition comprising a second amount of acetaminophen, tramadol, and a controlled release excipient selected from the group consisting of cross-linked high amylose starch, and hydroxypropylmethylcellulose, and a mixture thereof,
wherein, when tested in a U.S.P. Type III Apparatus at 20 dips per minute at 37° C. in 250 mL of a solution of potassium phosphate monobasic pH 6.8 for one hour, after which the solution is removed and replaced with a fresh 250 mL of potassium phosphate monobasic pH 6.8 for eleven hours, the acetaminophen and tramadol are released with the following kinetics
Time
Acetaminophen
Tramadol
(hours)
% release (by weight)
% release (by weight)
1
30-60
≦35
4
60-90
45-65
8
80-90
≦90
12
≧90
≧90,
and wherein a single bolus administration of the bilayer composition to a subject achieves (i) an effective plasma concentration of acetaminophen within about half an hour after initial administration, and (ii) effective plasma concentrations of acetaminophen and tramadol over a twelve hour period following initial administration.
2. The composition of claim 1 , wherein the second layer comprises both cross-linked high amylose starch and hydroxypropylmethylcellulose.
3. The composition of claim 1 , wherein the first layer comprises one or more of a granulation agent, a filler, a disintegrant, a lubricant, and a glidant.
4. The composition of claim 1 , wherein the second layer comprises one or more of a granulation agent, a filler, a binder, a lubricant, and a glidant.
5. The composition of claim 1 , wherein the second layer comprises from 5% w/w to 30% w/w of cross-linked high amylose starch.
6. The composition of claim 1 , wherein (i) the first layer comprises about 10% of the acetaminophen and the second layer comprises about 90% of the acetaminophen, (ii) the first layer comprises about 15% of the acetaminophen and the second layer comprises about 85% of the acetaminophen, (iii) the first layer comprises about 20% of the acetaminophen and the second layer comprises about 80% of the acetaminophen, (iv) the first layer comprises about 25% of the acetaminophen and the second layer comprises about 75% of the acetaminophen, (v) the first layer comprises about 30% of the acetaminophen and the second layer comprises about 70% of the acetaminophen, (vi) the first layer comprises about 35% of the acetaminophen and the second layer comprises about 65% of the acetaminophen, (vii) the first layer comprises about 40% of the acetaminophen and the second layer comprises about 60% of the acetaminophen, (viii) the first layer comprises about 45% of the acetaminophen and the second layer comprises about 55% of the acetaminophen, (ix) the first layer comprises about 50% of the acetaminophen and the second layer comprises about 50% of the acetaminophen, (x) the first layer comprises about 55% of the acetaminophen and the second layer comprises about 45% of the acetaminophen, (xi) the first layer comprises about 60% of the acetaminophen and the second layer comprises about 40% of the acetaminophen, (xii) the first layer comprises about 65% of the acetaminophen and the second layer comprises about 35% of the acetaminophen, or (xiii) the first layer comprises about 70% of the acetaminophen and the second layer comprises about 30 of the acetaminophen.
7. The composition of claim 1 , further comprising tramadol in the first layer.
8. The composition of claim 7 , wherein (i) the first layer comprises about 50% of the tramadol and the second layer comprises about 50% of the tramadol, (ii) the first layer comprises about 45% of the tramadol and the second layer comprises about 55% of the tramadol, (iii) the first layer comprises about 40% of the tramadol and the second layer comprises about 60% of the tramadol, (iv) the first layer comprises about 35% of the tramadol and the second layer comprises about 65% of the tramadol, (v) the first layer comprises about 30% of the tramadol and the second layer comprises about 70% of the tramadol, (vi) the first layer comprises about 25% of the tramadol and the second layer comprises about 75% of the tramadol, (vii) the first layer comprises about 20% of the tramadol and the second layer comprises about 80% of the tramadol, (viii) the first layer comprises about 15% of the tramadol and the second layer comprises about 85% of the tramadol, (ix) the first layer comprises about 10% of the tramadol and the second layer comprises about 90% of the acetaminophen, (x) the first layer comprises about 5% of the tramadol and the second layer comprises about 95% of the tramadol, or (xi) the first layer comprises about 0% of the tramadol and the second layer comprises about 100% of the tramadol.
9. The composition of claim 1 , wherein the first layer comprises from 70% to 90% w/w of acetaminophen, and the second layer comprises from 40% to 60% w/w acetaminophen and from 5% to 15% w/w of tramadol.
10. The composition of claim 1 , wherein a solvent accessible surface of the bilayer composition defines a score that permits the composition to be fractured along the score to produce two subunits, wherein the composition and the subunits each have dissolution profiles.
11. The composition of claim 10 , wherein at least one of the subunits has substantially the same release kinetics for both the acetaminophen and the tramadol as an intact form of the composition.
12. The composition of claim 11 , wherein the composition has a hardness in the range from 190 to 250 Newtons.
13. The composition of claim 10 , wherein the dissolution profiles of at least one of the subunits and an intact form of the composition have a similarity factor of at least 50.
14. The composition of claim 13 , wherein the composition has a hardness in the range from 190 to 250 Newtons.
15. The composition of claim 1 , wherein over a 12 hour period of time the ratio by weight of acetaminophen to tramadol released from the bilayer composition is greater than about 6:1.
16. A bilayer composition for the delivery of tramadol and acetaminophen, the bilayer composition comprising:
a. a first layer defining a rapid release portion of the composition and comprising acetaminophen; and
b. a second layer defining a sustained release portion of the composition and comprising acetaminophen, tramadol, and a controlled release excipient selected from the group consisting of cross-linked high amylose starch, hydroxypropylmethylcellulose, and a mixture thereof,
wherein, the bilayer composition, when administered to a subject in a single bolus, (i) achieves an effective plasma concentration of acetaminophen within about half an hour after initial administration, and (ii) releases the acetaminophen and the tramadol so that the ratio by weight of acetaminophen: tramadol in the plasma of the subject is at least 6:1 for at least 12 hours after administration to the subject.
17. A bilayer composition for the delivery of tramadol and acetaminophen, the bilayer composition comprising:
a. a first layer defining a rapid release portion of the composition and comprising from 70% to 90% w/w of acetaminophen, from 5% to 15% w/w starch, from 1% to 4% w/w microcrystalline cellulose, from 1% to about 3% w/w croscarmelose sodium, from 0.5% to 2% w/w sodium stearyl fumarate, and from 0.1% to 1% w/w colloidal silicon dioxide; and
b. a second layer adjacent the first layer and defining a sustained release portion of the composition and comprising from 40% to 60% w/w acetaminophen, from 5% to 15% w/w of tramadol, from 5% to 25% w/w cross-linked high amylose starch, from 5% to 10% w/w starch, from 1% to 6% w/w microcrystalline cellulose, from 5% to 15% w/w hydroxypropylmethyl cellulose, from 0% to 5% w/w copovidone, from 0.5% to 2% w/w sodium stearyl fumarate, and from 0.1% to 1% w/w colloidal silicone dioxide,
wherein a single bolus administration of the bilayer composition to a subject achieves an effective plasma concentration of acetaminophen within half an hour after initial administration.
18. A method of treating a mammal in need of analgesia, the method comprising administering to the mammal the composition of claim 1 so as to provide analgesia for at least twelve hours.
19. A method of treating a mammal in need of analgesia, the method comprising administering to the mammal the composition of claim 16 so as to provide analgesia for at least twelve hours.
20. A method of treating a mammal in need of analgesia, the method comprising administering to the mammal the composition of claim 17 so as to provide analgesia for at least twelve hours.